KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Change in Receivables: 2010-2025

Historic Change in Receivables for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to -$24,000.

  • Dynavax Technologies' Change in Receivables fell 100.19% to -$24,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 106.88%. This contributed to the annual value of $2.4 million for FY2024, which is 105.48% up from last year.
  • Per Dynavax Technologies' latest filing, its Change in Receivables stood at -$24,000 for Q3 2025, which was down 100.14% from $16.8 million recorded in Q2 2025.
  • Dynavax Technologies' Change in Receivables' 5-year high stood at $94.5 million during Q3 2021, with a 5-year trough of -$68.5 million in Q4 2021.
  • Moreover, its 3-year median value for Change in Receivables was $1.5 million (2023), whereas its average is -$1.3 million.
  • Per our database at Business Quant, Dynavax Technologies' Change in Receivables surged by 8,266.84% in 2021 and then plummeted by 1,116.07% in 2024.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Change in Receivables stood at -$68.5 million in 2021, then spiked by 123.92% to $16.4 million in 2022, then crashed by 114.23% to -$2.3 million in 2023, then crashed by 1,116.07% to -$28.4 million in 2024, then tumbled by 100.19% to -$24,000 in 2025.
  • Its Change in Receivables was -$24,000 in Q3 2025, compared to $16.8 million in Q2 2025 and $9.7 million in Q1 2025.